---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-25-008052"
form_type: "8-K"
ticker: "NTHI"
cik: "0001979414"
company_name: "NEONC TECHNOLOGIES HOLDINGS, INC."
filed_at: "2025-10-10T23:59:59+00:00"
generated_at: "2026-05-17T04:06:48.200980+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# NeOnc sets Oct 23 closing for $50M partnership with Quazar Investment after UAE approvals

## Summary
- Closing of $50M strategic partnership with Quazar Investment by Oct 23 after UAE tax/regulatory approvals.
- $15M of funds allocated for Phase 2B clinical trials and infrastructure in UAE and MENA region.
- Four upcoming clinical trials: NEO100-01, NEO100-02, NEO212 (Phase 2a/2b), and NEO100-03 (Phase 1 pediatric).
- NuroMENA Holdings, the Abu Dhabi-based operating subsidiary, incorporated on August 6, 2025.
- Quazar Investment has over $3.3B in AUM; partnership involves significant equity investment in NeOnc.

## SEC filing metadata
- accession: 0001829126-25-008052
- form_type: 8-K
- ticker: NTHI
- cik: 0001979414
- company_name: NEONC TECHNOLOGIES HOLDINGS, INC.
- filed_at: 2025-10-10T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1979414/000182912625008052/0001829126-25-008052-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1979414/000182912625008052/neonctechnologies_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-25-008052
- JSON: https://secwatch.observer/filing/0001829126-25-008052.json
- Plain text: https://secwatch.observer/filing/0001829126-25-008052.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.